MONKEYPOX VACCINE CLINICAL TRIAL

NIH RePORTER · NIH · N01 · $11,497,606 · view on reporter.nih.gov ↗

Abstract

To support a Phase II clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses.

Key facts

NIH application ID: 10710305
Project number: 75N91019D00024-0-759102200024-1
Recipient: LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator: THERESA ENGEL
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $11,497,606
Award type: —
Project period: 2022-09-19 → 2024-09-18